Monica Else

3.6k citations

42 papers · 2.0k indexed · h-index 22

Impact in

Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
Pathology and Forensic Medicine top 1%
- Lymphoma Diagnosis and Treatment

Papers in ⓘ

Genetics 40
- Chronic Lymphocytic Leukemia Research 40
Pathology and Forensic Medicine 33
- Lymphoma Diagnosis and Treatment 33

Co-authors: Daniel Catovsky (33 shared papers)Claire Dearden (18 shared papers)Estella Matutes (15 shared papers)Rachel Wade (9 shared papers)Sue Richards (8 shared papers)Zadie Davis (3 shared papers)Nnenna Osuji (5 shared papers)David Oscier (8 shared papers)
Journals: Blood (12 papers)British Journal of Haematology (9 papers)Haematologica (4 papers)Cancer (3 papers)Journal of Clinical Oncology (1 paper)
Partner nations: United Kingdom United States Italy

In The Last Decade

Monica Else

42 papers receiving 1.9k citations

Peers

Countries citing papers authored by Monica Else

Since Specialization

Citations

This map shows the geographic impact of Monica Else's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica Else with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica Else more than expected).

Fields of papers citing papers by Monica Else

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monica Else. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica Else. The network helps show where Monica Else may publish in the future.

Co-authors

The 25 scholars most cited alongside Monica Else, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Monica Else Line = papers co-authored together Monica Else links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial The Lancet ·Daniel Catovsky, (unknown), Estella Matutes, (unknown), Martin J.S. Dyer, R. F. Bezares, A R Pettitt, (unknown), (unknown), (unknown), William Hamilton, (unknown), A J Smith, AG Bosanquet, Zadie Davis, (unknown), Monica Else, Rachel Wade, Peter Hillmen	2007	482
2	Long‐term follow‐up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis British Journal of Haematology ·Monica Else, Claire Dearden, Estella Matutes, Juan Garcia‐Talavera, A. Z. S. Rohatiner, S.A. Johnson, N T O'Connor, A. P. Haynes, Nnenna Osuji, Francesco Forconi, Francesco Lauria, Daniel Catovsky	2009	175
3	The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial Blood ·David Oscier, Matthew Rose‐Zerilli, Nils Winkelmann, David González de Castro, B Moreno Gómez, Jade Forster, Helen Parker, Anton Parker, Anne Gardiner, Andrew Collins, Monica Else, Nicholas C.P. Cross, Daniel Catovsky, Jonathan C. Strefford	2012	150
4	Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma Blood ·Matthew Jenner, Paola Leone, Brian A. Walker, Fiona M. Ross, David C. Johnson, David González, Laura Chiecchio, Elisabet Dachs Cabanas, Gian Paolo Dagrada, Mathew Nightingale, R.K.M. Protheroe, David Stockley, Monica Else, Nicholas J. Dickens, Nicholas C.P. Cross, Faith E. Davies, Gareth J. Morgan	2007	100
5	The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia Blood ·Claire Dearden, Rachel Wade, Monica Else, Sue Richards, Don Milligan, Terry J. Hamblin, Daniel Catovsky	2007	92
6	Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation Haematologica ·David Oscier, Rachel Wade, Zadie Davis, Alison Morilla, Giles Best, Stephen J. Richards, Monica Else, Estella Matutes, D. Catovsky	2010	81
7	Deletions of CDKN2C in Multiple Myeloma: Biological and Clinical Implications Clinical Cancer Research ·Paola Leone, Brian A. Walker, Matthew Jenner, Laura Chiecchio, Gian Paolo Dagrada, R.K.M. Protheroe, David C. Johnson, Nicholas J. Dickens, Jose Luis R. Brito, Monica Else, David González, Fiona M. Ross, Selina Chen‐Kiang, Faith E. Davies, Gareth J. Morgan	2008	80
8	Long remissions in hairy cell leukemia with purine analogs Cancer ·Monica Else, Rosa Ruchlemer, Nnenna Osuji, Ilaria Del Giudice, Estella Matutes, A Woodman, Andrew Wotherspoon, John Swansbury, Claire Dearden, Daniel Catovsky	2005	79
9	Revised guidelines for the diagnosis and management of hairy cell leukaemia and hairy cell leukaemia variant* British Journal of Haematology ·Gail Jones, Nilima Parry‐Jones, Bridget S. Wilkins, Monica Else, Daniel Catovsky	2011	54
10	Alemtuzumab therapy in T-cell prolymphocytic leukemia: comparing efficacy in a series treated intravenously and a study piloting the subcutaneous route Blood ·Claire Dearden, Amit Khot, Monica Else, Michael R. Hamblin, Effie Grand, Ashok Roy, Saman Hewamana, Estella Matutes, Daniel Catovsky	2011	51
11	The clinical significance of patients' sex in chronic lymphocytic leukemia Haematologica ·D. Catovsky, Rachel Wade, Monica Else	2014	51
12	Long-term follow-up after purine analogue therapy in hairy cell leukaemia Best Practice & Research Clinical Haematology ·Monica Else, Claire Dearden, Daniel Catovsky	2015	50
13	Long-term results for pentostatin and cladribine treatment of hairy cell leukemia Leukemia & lymphoma ·Claire Dearden, Monica Else, Daniel Catovsky	2011	48
14	Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma British Journal of Haematology ·Monica Else, Ana Marín‐Niebla, Fátima De la Cruz, Paul Batty, Eduardo Ríos, Claire Dearden, Daniel Catovsky, Estella Matutes	2012	45
15	The prognostic impact of clinical and molecular features in hairy cell leukaemia variant and splenic marginal zone lymphoma British Journal of Haematology ·Sarah L. Hockley, Monica Else, Alison Morilla, Andrew Wotherspoon, Claire Dearden, Daniel Catovsky, David González, Estella Matutes	2012	44
16	Patients’ experience of chronic lymphocytic leukaemia: baseline health‐related quality of life results from the LRF CLL4 trial British Journal of Haematology ·Monica Else, Alastair G. Smith, Kim Cocks, Sue Richards, Shirley Crofts, Rachel Wade, Daniel Catovsky, (unknown)	2008	40
17	Rituximab with pentostatin or cladribine: an effective combination treatment for hairy cell leukemia after disease recurrence Leukemia & lymphoma ·Monica Else, Claire Dearden, Estella Matutes, Francesco Forconi, Francesco Lauria, Humayun N. Ahmad, Susan S. Kelly, Anandika Liyanage, Vijitha Ratnayake, Jagadeesan Shankari, Ioana Whalley, Daniel Catovsky	2011	39
18	The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia Cancer ·Monica Else, Nnenna Osuji, Francesco Forconi, Claire Dearden, Ilaria Del Giudice, Estella Matutes, Andrew Wotherspoon, Francesco Lauria, Daniel Catovsky	2007	35
19	Chlorambucil—Still Not Bad: A Reappraisal Clinical Lymphoma Myeloma & Leukemia ·Daniel Catovsky, Monica Else, Sue Richards	2011	34
20	Combinations of ZAP-70, CD38 and IGHV mutational status as predictors of time to first treatment in CLL Leukemia & lymphoma ·Alison Morilla, David González de Castro, Ilaria Del Giudice, Nnenna Osuji, Monica Else, Ricardo Morilla, Vasantha Brito Babapulle, Hannah C. Rudenko, Estella Matutes, Claire Dearden, Daniel Catovsky, Gareth J. Morgan	2008	32

About Monica Else

Monica Else is a scholar working on Genetics, Pathology and Forensic Medicine, Immunology, Oncology and Hematology, having authored 42 papers that have together received 2.0k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (40 papers), Lymphoma Diagnosis and Treatment (33 papers), Immunodeficiency and Autoimmune Disorders (12 papers), Viral-associated cancers and disorders (9 papers), Glycosylation and Glycoproteins Research (3 papers), Toxin Mechanisms and Immunotoxins (2 papers), Acute Lymphoblastic Leukemia research (2 papers) and Advanced Breast Cancer Therapies (2 papers). The work is most often cited by research in Genetics (1.6k citations), Pathology and Forensic Medicine (1.2k citations), Immunology (712 citations), Hematology (320 citations) and Oncology (403 citations). Monica Else has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Daniel Catovsky, Claire Dearden, Estella Matutes, Rachel Wade, Sue Richards, Zadie Davis, Nnenna Osuji, David Oscier, Peter Hillmen and Martin J.S. Dyer. Their work appears in journals such as Blood, British Journal of Haematology, Haematologica, Cancer and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact